Industry Symposium by Bayer
IND 31 - Future Directions in Liver Disease – preparing for increased prevalence and optimizing collaboration for better patient care
(1) Where is Liver Disease heading in Europe?: An Outlook and Perspective from the European Association of the Study of the Liver (EASL).
(2) Best practices in screening/surveillance, diagnosis and follow-up. Current challenges in HCC treatment stratification and response prediction.
(3) Precision Imaging in Radiology: Current Options and Future Potential.
(2) Best practices in screening/surveillance, diagnosis and follow-up. Current challenges in HCC treatment stratification and response prediction.
(3) Precision Imaging in Radiology: Current Options and Future Potential.
20 min
Where is Liver Disease heading in Europe?: An Outlook and Perspective from the European Association of the Study of the Liver (EASL)
Thomas Berg, LEIPZIG / Germany
20 min
Best practices in screening/surveillance, diagnosis and follow-up. Current challenges in HCC treatment stratification and response prediction
Muşturay Karçaaltincaba, Ankara / Turkey
20 min
Precision Imaging in Radiology: Current Options and Future Potential
Timo Alexander Auer, Berlin / Germany
Lectures
1
Where is Liver Disease heading in Europe?: An Outlook and Perspective from the European Association of the Study of the Liver (EASL)
20:00Thomas Berg, LEIPZIG / DE
2
Best practices in screening/surveillance, diagnosis and follow-up. Current challenges in HCC treatment stratification and response prediction
20:00Muşturay Karçaaltincaba, Ankara / TR
3
Precision Imaging in Radiology: Current Options and Future Potential
20:00Timo Alexander Auer, Berlin / DE
Gesine Knobloch
Berlin / Germany
Thomas Berg
LEIPZIG / GermanyMuşturay Karçaaltincaba
Ankara / TurkeyTimo Alexander Auer
Berlin / Germany